Major Depressive Disorder Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Adjunctive NBI 1065845 in Adult Subjects With Major Depressive Disorder (MDD) (SAVITRI STUDY)
The purpose of this study is to evaluate the efficacy of NBI-1065845 compared with placebo used in addition to oral antidepressants in adults with MDD on improving symptoms of depression.
n/a
| NCT number | NCT05203341 |
| Study type | Interventional |
| Source | Neurocrine Biosciences |
| Contact | Neurocrine Medical Information Call Center |
| Phone | 877-641-3461 |
| [email protected] | |
| Status | Recruiting |
| Phase | Phase 2 |
| Start date | February 21, 2022 |
| Completion date | October 2023 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
||
| Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
| Recruiting |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
| Recruiting |
NCT05427981 -
Anti-suicidal Effects of Buprenorphine In Depressed Individuals
|
Phase 3 | |
| Recruiting |
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A | |
| Suspended |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
Early Phase 1 | |
| Not yet recruiting |
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 | |
| Recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
| Completed |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
| Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
| Recruiting |
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A | |
| Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
| Recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
| Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
| Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
| Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
| Recruiting |
NCT04422652 -
Combination of Novel Therapies for CKD Comorbid Depression
|
Phase 2 | |
| Completed |
NCT04799405 -
Home-based tDCS in Major Depressive Disorder
|
N/A | |
| Recruiting |
NCT03363919 -
Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression
|
N/A | |
| Recruiting |
NCT03708159 -
Maintenance of Response After rTMS for Depression Using tDCS
|
N/A |